ad image

Community

Richard Snyder, Ph.D.
Richard Snyder, Ph.D.

Vice President, Science and Technology, Viral Vector Services Pharma Services, Thermo Fisher Scientific

Dr. Snyder was the founder of Florida Biologix, which was spun out of the University of Florida in 2015 and merged to create Brammer Bio in 2016. Dr. Snyder has been investigating virus biology, vector development, cGMP manufacturing and analytical technologies, and viral vector–mediated gene transfer for over 32 years. Dr. Snyder received his doctoral degree in microbiology from the State University of New York at Stony Brook and obtained his BA in biology from Washington University in St. Louis.
8 Contributions1 / 1
Production of AAV Vectors Using Suspension Mammalian and Insect Cell Systems
AAV Vector Production

Production of AAV Vectors Using Suspension Mammalian and Insect Cell Systems

Richard Snyder, Ph.D.; Jessica Tate, Ph.D.; Hetal Brahmbhatt, Ph.D.; Steven G. Milian, M.S.

Thermo Fisher Scientific

PAP-Q3-19-CL-006Oct 28, 2019
Accelerating The Development of Viral Vector Manufacturing Processes
Viral Vector Manufacturing

Accelerating The Development of Viral Vector Manufacturing Processes

Richard Snyder, Ph.D.; Clive Glover, Ph.D.; Rajiv Vaidya, Ph.D.; Matt Niloff

Thermo Fisher Scientific

PAP-Q2-2019-CL-009May 24, 2019
Digital Droplet PCR for Viral Vector Analysis
QPCR

Digital Droplet PCR for Viral Vector Analysis

Richard Snyder, Ph.D.; Susan D'Costa, Ph.D.; Sushma Ogram, Ph.D.; Diego Matayoshi

Thermo Fisher Scientific

PAP-Q1-2019-CL-005Mar 12, 2019
Analytical Methodologies Utilized in Therapeutic Viral Vector Manufacturing
Cell and Gene Therapy

Analytical Methodologies Utilized in Therapeutic Viral Vector Manufacturing

Richard Snyder, Ph.D.; Sushma Ogram, Ph.D.; Tony DeFusco

Thermo Fisher Scientific

PAP-Q3-18-CL-001Oct 02, 2018
Overcoming Raw Material and Supply Chain Challenges in Viral Vector Manufacturing
Cell and Gene Therapy

Overcoming Raw Material and Supply Chain Challenges in Viral Vector Manufacturing

Richard Snyder, Ph.D.; Christopher K. Murphy; Susan D'Costa, Ph.D.; Cameron Jones

Thermo Fisher Scientific

PAP-Q2-18-CL-011May 29, 2018
Transient Transfection at a Large Scale for Flexibility in Clinical and Commercial Vector Manufacturing
Transient Transfection

Transient Transfection at a Large Scale for Flexibility in Clinical and Commercial Vector Manufacturing

Richard Snyder, Ph.D.; Scott Jeffers, Ph.D.; Ying Cai, Ph.D.

Thermo Fisher Scientific

PAP-Q3-17-CL-005Sep 15, 2017
Supporting the Tech Transfer Continuum for Cell & Gene Therapies
CDMO

Supporting the Tech Transfer Continuum for Cell & Gene Therapies

Richard Snyder, Ph.D.; Matthew Caple; Jessica Tate, Ph.D.

Thermo Fisher Scientific

PAP-Q2-17-CL-003Jun 05, 2017
Achieving Large-Scale Cell and Gene Therapy Manufacturing

Achieving Large-Scale Cell and Gene Therapy Manufacturing

Richard Snyder, Ph.D.; Steve Kasok

Thermo Fisher Scientific

PAP-Q02-16-CL-010Apr 01, 2016
1 / 1